ZyVersa Therapeutics Employee Directory

ZyVersa Therapeutics corporate office is located in 2200 N Commerce Pkwy Ste 208, Weston, Florida, 33326, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

Finance

2

Sales

2

Medical & Health

1

Marketing

1

C-Suite

1

Key Employees of ZyVersa Therapeutics

  • PW
    United States flag for contact location.
    Peter Wolfe

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PG
    United States flag for contact location.
    Pablo Guzman

    Chief Medical Officer, Zyversa Therapeutics

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

ZyVersa Therapeutics Global Presence

globalPresence illustration
North America1-10
Africa1-10

Index of contact profiles from ZyVersa Therapeutics

Hundreds of professionals searching for ZyVersa Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at ZyVersa Therapeutics

Explore people who held key positions, contributed to ZyVersa Therapeutics's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Florida, United States

Frequently Asked Questions Regarding ZyVersa Therapeutics Employees

How many employees does ZyVersa Therapeutics have?
ZyVersa Therapeutics has 1-10 employees
Who is the CFO of ZyVersa Therapeutics?
ZyVersa Therapeutics’s CFO is Peter Wolfe
Who are ZyVersa Therapeutics key employees?
Some of ZyVersa Therapeutics key employees are Peter Wolfe, Pablo Guzman
Where is ZyVersa Therapeutics located?
ZyVersa Therapeutics’s headquarters are located at 2200 N Commerce Pkwy Ste 208, Weston, Florida, 33326, United States
How do I contact ZyVersa Therapeutics?
ZyVersa Therapeutics Contact Info: Phone number: (754) 231-1688 Website: www.zyversa.com
What does ZyVersa Therapeutics do?

ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with renal or inflammatory diseases who have significant unmet medical needs. Our development pipeline includes phase 2a-ready VAR 200, a cholesterol efflux mediator for treatment of... a rare kidney disease, focal segmental glomerulosclerosis (FSGS). VAR 200 has potential to treat other kidney diseases, such as Alport Syndrome and Diabetic Kidney Disease. Our pipeline also includes a novel inflammasome ASC inhibitor with potential to treat multiple CNS and other inflammatory diseases.Read More

Is ZyVersa Therapeutics a public company?
Yes, ZyVersa Therapeutics is a public company and is traded under the symbol ZVSA
See more information about ZyVersa Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.